This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer Logo
BAYERPROYour Resource Portal
  • Cardiology
  • Beyonttra®▼ (acoramidis)
  • Oncology
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • Women's Health
  • Jaydess® ▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Ophthalmology
  • Eylea® (aflibercept) 8mg
Products
  • Cardiology
  • Oncology
  • Ophthalmology
  • Women's Health
  • Cardiology Resources
  • Oncology Resources
  • Ophthalmology Resources
  • Women's Health Resources
  • Bayer Events & On Demand Webinars
  • Cardiology Events & On Demand Webinar
  • Oncology Events & On Demand Webinars
  • Ophthalmology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Cardiology Learning Zone
  • Oncology Learning Zone
  • Ophthalmology Learning Zone
  • Women's Health Learning Zone
  • Cardiology Podcasts
  • Oncology Podcasts
  • Ophthalmology Podcasts
closesearch
Recent Searches
    You are now leaving BayerPRO

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

     Name BayerPRO IRE Above Brand Header

    Cardiology: On Demand & Webinars

    ATTR-CM Expert Series
    Join us as Prof Fontana takes us through the clinical data, patient cases and other aspects related to ATTR-CM. | Beyonttra®▼ (acoramidis)
    Beyonttra®▼ (acoramidis) Prescribing Information
    PP-PF-CAR-IE-0015-1, March 2026
    ATTR-CM Nurse Expert Series
    This short series focuses on clinical and dietary aspects of ATTR-CM management. | Beyonttra®▼ (acoramidis)
    Beyonttra®▼ (acoramidis) Prescribing Information
    PP-PF-CAR-IE-0016-1, March 2026
    Expert Insights into ATTR-CM
    This series explores the complexities of ATTR-CM. Join us in a discussion on diagnosis, treatment, and the importance of a multidisciplin...
    Beyonttra®▼ (acoramidis) Prescribing Information
    PP-PF-CAR-IE-0017-1, April 2026
    ATTR-CM Masterclass Series
    This comprehensive series is designed to provide healthcare professionals with an in-depth understanding of transthyretin amyloid cardiom...
    Beyonttra®▼ (acoramidis) Prescribing Information
    PP-PF-CAR-IE-0018-1, April 2026